H.R. 6433 (112th): FDA User Fee Corrections Act of 2012

Introduced:
Sep 19, 2012 (112th Congress, 2011–2013)
Sponsor:
Rep. Fred Upton [R-MI6]
Status:
Signed by the President
Slip Law:
This bill became Pub.L. 112-193.

The bill’s title was written by the bill’s sponsor. H.R. stands for House of Representatives bill.

(About Ads | Advertise Here)
Status

This bill was enacted after being signed by the President on October 5, 2012.

Progress
Introduced Sep 19, 2012
Referred to Committee Sep 19, 2012
Passed House Sep 19, 2012
Passed Senate Sep 22, 2012
Signed by the President Oct 05, 2012
Cosponsors
1 cosponsors (1D) (show)
Committees

House Energy and Commerce

The committee chair determines whether a bill will move past the committee stage.

Full Title

To make corrections with respect to Food and Drug Administration user fees.

Summary

No summaries available.

Text

Read Bill Text »

Last updated Jan 01, 2012.
2 pages

Primary Source

View on THOMAS (The Library of Congress)

GovTrack gets most information from THOMAS, which is updated generally one day after events occur. Activity since the last update may not be reflected here.

Citation

Click a format for a citation suggestion:

GovTrack’s Bill Summary

We don’t have a summary available yet.

Library of Congress Summary

The summary below was written by the Congressional Research Service, which is a nonpartisan division of the Library of Congress.

10/5/2012--Public Law. (This measure has not been amended since it was introduced.
The summary of that version is repeated here.) FDA User Fee Corrections Act of 2012 - Amends the Federal Food, Drug, and Cosmetic Act (FFDCA), as amended by the Food and Drug Administration Safety and Innovation Act (P.L. 112-144), to:
(1) make clerical corrections to provisions of such Act; and
(2) eliminate the restriction that appropriated funds shall be available only for payment of increases in the cost of reviewing medical device applications, including related personnel costs.
Specifies due dates in FY2013 under FFDCA for the drug master file fee, the abbreviated new drug application and prior approval supplement filing fees, and the generic drug facility and active pharmaceutical ingredient facility fees.

House Republican Conference Summary

The summary below was written by the House Republican Conference, which is the caucus of Republicans in the House of Representatives.

No summary available.

House Democratic Caucus Summary

The House Democratic Caucus does not provide summaries of bills.

So, yes, we display the House Republican Conference’s summaries when available even if we do not have a Democratic summary available. That’s because we feel it is better to give you as much information as possible, even if we cannot provide every viewpoint.

We’ll be looking for a source of summaries from the other side in the meanwhile.

The bill contains the following citations to other parts of U.S. law:

United States Code

The United States Code is the compilation of permanent laws enacted by Congress. Temporary and other non-permanent laws do not appear in the United States Code. (About half of the United States Code is the law itself, called positive law. The other half is merely a compilation of the laws but has no legal significance.)